Science Explorer Back to mapMap
Discussion
Researcher · Universität Ulm · Germany

Stephan Stilgenbauer

Stephan Stilgenbauer publishes mostly in Genetics, Pathology and Forensic Medicine and Immunology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Immunodeficiency and Autoimmune Disorders.

ORCID 0000-0002-6830-9296 OpenAlex
World rank
#85,623
of 7,710,434 ranked researchers
Rank in Germany
#4,649
of 364,343
Works
1,254
Citations
77k
Citations per work
61.2
h-index
130
i10-index 554Top 0.1% in Genetics (Medicine)
Stephan Stilgenbauer

What does Stephan Stilgenbauer research?

Stephan Stilgenbauer's work is mostly in Medicine (57%), Immunology and Microbiology (12%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 710 works · 56.6% of their workMedicine: 710 works · 56.6% of their workGenetics: 354 works · 28.2% of their workPathology and Forensic Medicine: 214 works · 17.1% of their workOncology: 85 works · 6.8% of their workHematology: 56 works · 4.5% of their workLife Sciences: 273 works · 21.8% of their workImmunology and Microbiology: 155 works · 12.4% of their workImmunology: 155 works · 12.4% of their workBiochemistry, Genetics and Molecular Biology: 118 works · 9.4% of their workMolecular Biology: 118 works · 9.4% of their workEverything else: 271 works · 21.6% of their workTHEIR WORKStephanStilgenbauer1,254works
Life Sciences22%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine71056.6%
    1. Immunology and Microbiology15512.4%
    2. Biochemistry, Genetics and Molecular Biology1189.4%
  3. Everything else27121.6%
  1. 1Genetics28% of their works
  2. 2Pathology and Forensic Medicine17% of their works
  3. 3Immunology12% of their works
  4. 4Molecular Biology9% of their works
  5. 5Oncology7% of their works
  6. 6Hematology4% of their works

Research topics

Which keywords describe Stephan Stilgenbauer's research?

The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Genetic Mutations and Primary Immunodeficiency.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab1,2922 topics
  2. Prognostic Factors9292 topics
  3. Chronic Lymphocytic Leukemia8231 topic
  4. Genomic Aberrations8231 topic
  5. Classification4691 topic
  6. Lymphoma4691 topic
  7. Genetic Mutations2641 topic
  8. Primary Immunodeficiency2641 topic
  9. Glycosylation1262 topics
  10. Acute Lymphoblastic Leukemia1061 topic
  11. Childhood Cancer1061 topic
  12. Breast Cancer871 topic
  13. CDK4/6 Inhibitors871 topic
  14. BCR-ABL861 topic
  15. Imatinib861 topic
  16. Cancer661 topic
  17. Glycans661 topic
  18. Fc Receptors601 topic
  19. Therapeutic Antibodies601 topic

Where does Stephan Stilgenbauer work?

Stephan Stilgenbauer's main affiliation in the publication record is Universität Ulm, Germany.

How many publications and citations does Stephan Stilgenbauer have?

OpenAlex counts 1,254 works and 76,775 citations for Stephan Stilgenbauer, an h-index of 130, ranking #85,623 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stephan Stilgenbauer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.